• A unique collection of 709 bone formation compounds for high throughput screening (HTS) and high content screening (HCS).
• A useful tool for the study of bone disease drugs and pharmacology.
• Target diverse, medicinally active and cell permeable.
• Bioactivity and safety confirmed by preclinical research and clinical trials. Some have been approved by FDA.
• More detailed compound information with structure, IC50, and other chemical & biological data.
• High purity and quality validated by NMR and LC/MS.